Altoida
Altoida Secures Investment from Hikma Ventures to Drive Better Clinical Outcomes for Brain Diseases
Altoida reports the FDA-cleared and CE Mark-approved medical device and brain health data platform detects Alzheimer's Disease (AD) up to ten years prior to onset - with up to 94% accuracy.
